Evidence map›Paper›PMID 24125583›Full record

ArticleNano letters2013

Nanoscale ligand spacing influences receptor triggering in T cells and NK cells.

Derfogail Delcassian, David Depoil, Dominika Rudnicka, Mengling Liu, Daniel M Davis, Michael L Dustin, Iain E Dunlop

Open access · greenAbstract read
In one paragraph

Article in Nano letters, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 123 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. DNA origami patterning of synthetic T cell receptors reveals spatial control of the sensitivity and kinetics of signal activation.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Derfogail DelcassianDepartment of Materials and ‡Division of Cell and Molecular Biology, Imperial College London , Exhibition Road, London SW7 2AZ, United Kingdom.
David Depoil
Dominika Rudnicka
Mengling Liu
Daniel M Davis
Michael L Dustin
Iain E Dunlop
University of Manchester · GBUniversity of Oxford · GB

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
Nanomedicine development center for mechanobiologyPN2EY016586 · NEI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DUSTIN, MICHAEL LORAN · 2005 to 2014
$23.0M
Medical Research Council G0500563Medical Research Council G0900850Medical Research Council G1001044NCI NIH HHS P30 CA016087NEI NIH HHS PN2 EY016586
6 · The paper itself

Abstract

Bioactive nanoscale arrays were constructed to ligate activating cell surface receptors on T cells (the CD3 component of the TCR complex) and natural killer (NK) cells (CD16). These arrays are formed from biofunctionalized gold nanospheres with controlled interparticle spacing in the range 25-104 nm. Responses to these nanoarrays were assessed using the extent of membrane-localized phosphotyrosine in T cells stimulated with CD3-binding nanoarrays and the size of cell contact area for NK cells stimulated with CD16-binding nanoarrays. In both cases, the strength of response decreased with increasing spacing, falling to background levels by 69 nm in the T cell/anti-CD3 system and 104 nm for the NK cell/anti-CD16 system. These results demonstrate that immune receptor triggering can be influenced by the nanoscale spatial organization of receptor/ligand interactions.

Indexed as

NanotechnologyCD3 ComplexHumansKiller Cells, NaturalNanoparticlesReceptor-CD3 Complex, Antigen, T-CellReceptors, Cell SurfaceReceptors, IgGReceptors, Natural Killer CellT-LymphocytesCD3 ComplexReceptor-CD3 Complex, Antigen, T-CellReceptors, Cell SurfaceReceptors, IgGReceptors, Natural Killer Cell

Identifiers

PMID24125583
PMCPMC4288448
OpenAlexW2040522878

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.